The average one-year price target for Tactile Systems Technology (NasdaqGM:TCMD) has been revised to $17.17 / share. This is ...

The new long-term results follow two-month data released at ASCO in June 2025 and are drawn from the largest prospective, randomized controlled study ever conducted among head and neck cancer ...

For the full year 2025, CFO Birkemeyer reported, "we now expect total revenue in the range of $310 million to $315 million, representing growth of approximately 6% to 8% year-over-year." The guidance ...

Tactile Systems (NASDAQ:TCMD) extended its post-market losses on Tuesday after the Minnesota-based MedTech fell short of Street forecasts for Q3 2024 revenue, prompting BTIG to downgrade its stock to ...

Improved care has led to a much higher survival rate among cancer patients. It’s also produced an unintended consequence: the problem of how to treat lymphedema, the chronic swelling that occurs, ...

Shares of Tactile Systems Technology (NASDAQ: TCMD) fell as much as 18.5% early Tuesday, then settled to close down 3.2% after the medical technology company announced mixed quarterly results and ...

“We are pleased to report impressive performance during the fourth quarter, which resulted in expected revenue growth of 21% to 22% year-over-year,” said Gerald R. Mattys, Chief Executive Officer of ...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE ...

Tactile Systems Technology has seen its fair value estimate revised upward from $13.50 to $16.83 per share. This change is driven by analyst optimism surrounding the company’s market positioning and ...

Tactile Systems Technology announced mixed fourth-quarter results, beating earnings estimates and falling slightly short on revenue. The medical technology company is enjoying strong operating ...